Defining a Hodgkin Lymphoma Population for Novel Therapeutics after Relapse from Autologous haematopoietic Cell Transplantation

S Arai, M Fanale, S DeVos, A Engert, T Illidge, P Borchmann, A Younes, F Morschhauser, SJ Horning

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{72fc30528c2945188c0b4cdbf97e5c63,

title = "Defining a Hodgkin Lymphoma Population for Novel Therapeutics after Relapse from Autologous haematopoietic Cell Transplantation",

author = "S Arai and M Fanale and S DeVos and A Engert and T Illidge and P Borchmann and A Younes and F Morschhauser and SJ Horning",

year = "2013",

month = jun,

day = "5",

language = "English",

volume = "54",

pages = "2531--2533",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "11",

}

TY - JOUR

T1 - Defining a Hodgkin Lymphoma Population for Novel Therapeutics after Relapse from Autologous haematopoietic Cell Transplantation

AU - Arai, S

AU - Fanale, M

AU - DeVos, S

AU - Engert, A

AU - Illidge, T

AU - Borchmann, P

AU - Younes, A

AU - Morschhauser, F

AU - Horning, SJ

PY - 2013/6/5

Y1 - 2013/6/5

M3 - Article

SN - 1042-8194

VL - 54

SP - 2531

EP - 2533

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 11

ER -